Samsara BioCapital, LLC

Holdings History for Elevation Oncology, Inc. - Common Stock, par value $0.0001 per share (ELEV)

Symbol: ELEV
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2023		-0.22%	$0	0	-830,565	-100%		Q3 2023
30 Jun 2023	0.22%	0%	$1,262,459	830,565	0		$1.52	Q2 2023
31 Mar 2023	0.33%	0%	$1,578,074	830,565	0		$1.90	Q1 2023
31 Dec 2022	0.17%	0%	$789,037	830,565	0		$0.9500	Q4 2022
30 Sep 2022	0.22%	0%	$939,000	830,565	0		$1.13	Q3 2022
30 Jun 2022	0.31%	-0.04%	$1,163,000	830,565	-101,675	-11%	$1.40	Q2 2022
31 Mar 2022	0.59%	0%	$2,349,000	932,240	0		$2.52	Q1 2022
31 Dec 2021	1.1%	0%	$5,612,000	932,240	0		$6.02	Q4 2021
30 Sep 2021	1.2%	+0%	$7,262,000	932,240	+1	+0%	$7.79	Q3 2021
30 Jun 2021	1.7%	+1.7%	$12,650,000	932,239	+932,239	NEW	$13.57	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.